These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26966353)

  • 1. Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.
    El-Say KM
    Drug Des Devel Ther; 2016; 10():825-39. PubMed ID: 26966353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs.
    El-Say KM; El-Helw AR; Ahmed OA; Hosny KM; Ahmed TA; Kharshoum RM; Fahmy UA; Alsawahli M
    Pharm Dev Technol; 2015; 20(6):738-46. PubMed ID: 24856961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology.
    Agrawal G; Wakte P; Shelke S
    Endocr Metab Immune Disord Drug Targets; 2017; 17(2):149-165. PubMed ID: 28472911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method.
    Kim BK; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2002; 19(6):811-22. PubMed ID: 12569029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres.
    El-Bary AA; Aboelwafa AA; Al Sharabi IM
    AAPS PharmSciTech; 2012 Mar; 13(1):75-84. PubMed ID: 22130789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
    Rawat M; Saraf S
    J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon specific chitosan microspheres for chronotherapy of chronic stable angina.
    Jose S; Prema MT; Chacko AJ; Thomas AC; Souto EB
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):277-83. PubMed ID: 21194900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of sustained release triptolide microspheres.
    Zeng HL; Qiu Q; Fu TX; Deng AP; Xie XY
    PLoS One; 2023; 18(10):e0292861. PubMed ID: 37856525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier.
    Tian S; Li J; Tao Q; Zhao Y; Lv Z; Yang F; Duan H; Chen Y; Zhou Q; Hou D
    Int J Nanomedicine; 2018; 13():415-428. PubMed ID: 29391798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation.
    Ranjan OP; Shavi GV; Nayak UY; Arumugam K; Averineni RK; Meka SR; Sureshwar P
    Arch Pharm Res; 2011 Nov; 34(11):1919-29. PubMed ID: 22139691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.